U.S. pharma huge copyright scrapped two experimental weight loss products last yr—a as soon as-day by day tablet, lotiglipron, due to elevated liver enzymes and also a 2 times-every day pill, danuglipron, as a result of powerful Unwanted side effects—but CEO Albert Bourla has explained the company is decided to “Participate in and gain” wit